Dr Mike England joins as medical director for UK & ROI
Category: Uncategorized
Updated Date: Wed, 29 Apr 2020 00:00:00 EDT
Updated Date: Wed, 29 Apr 2020 00:00:00 EDT
Updated Date: Wed, 29 Apr 2020 00:00:00 EDT
Updated Date: Wed, 29 Apr 2020 00:00:00 EDT
Updated Date: Wed, 29 Apr 2020 00:00:00 EDT
Amgen is planning to file for FDA approval of Otezla in mild to moderate plaque psoriasis based on […]
The approval gives NSCLC patients whose tumours carry the MET exon 14 skipping mutation a new treatment option
RBX2660 may bring an innovative therapeutic option to patients suffering from C. diff